Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer

Nature Medicine

Volumn 2, Issue 4, 1996, Pages 461-462

  Murray, Graeme I ^a   Duncan, Margaret E ^a   O'Neil, Pauline ^a   Melvin, William T ^a   Fothergill, John E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER STAGING; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

MUS MUSCULUS;

EID: 0029952713     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0496-461     Document Type: Article

References (13)

1. Hart I.R. & Saini, A. Biology of tumour metastasis. Lancet 339, 1453-1457 (1992).
2. Liotta, L.A., Steeg, P.S. & Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64, 327-336 (1991).
3. Stetler-Stevenson W.G., Liotta, L.A. & Kleiner, D.E. Extracellular matrix 6: Role of matrix metalloproteinases in tumour invasion and metastasis. FASEB J. 7, 1434-1441 (1992).
4. Wang, X., Fu, X., Brown, P.D., Crimmin, M.J. & Huffman, R,M. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54, 4726-1728 (1994).
5. Duncan, M.E., McAleese, S.M., Booth, N.A., Melvin, W.T. & Fothergill, J.E. A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific gamma isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences. J. Immunol. Meth. 151, 227-236 (1992).
6. Van Der Stappen, J.W.J., Hendriks, T. & Wobbes, T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int. J. Cancer 45, 1071-1078 (1990).
7. Irimura, T., Yamori, T., Bennett, S.C., Ota, D.M. & Cleary, K.R. The relationship of collagenase activity to stage of human colorectal tumours. Int. J. Cancer 40, 24-31 (1987).
8. Hewitt, R.E. et al. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int. J. Cancer 49, 666-672 (1991).
9. Gray, S.T., Yun, K., Motoori, T. & Kuys, Y.M. Interstitial collagenase gene expression in colonic neoplasia. Am. J. Pathol. 143, 663-671 (1993).
10. Urbanski, S.J., Edwards, D.R., Hershfield, N., Huchcroft, S.A., Shaffer, E., Sutherland, L. & Kossakowska, A.E. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn. Mol. Pathol. 2, 81-89 (1993).
11. Fenoglio-Preiser, C.M. & Noffsinger, A.E. Epithelial tumours and tumour-like conditions, in Gastro-intestinal and Oesophageal Pathology (ed. Whitehead, R.) 863-892 (Churchill Livingstone, Edinburgh, 1995).
12. Brown, P.D. Matrix metalloproteinase inhibitors: A new class of anticancer agent. Curr. Opin. Invest. Drug 2, 617-626 (1993).
13. Murray, G.I., Duncan, M.E., Melvin, W.T. & Fothergill, J.E. Immunohistochemistry of neuron specific enolase with gamma-subunit specific anti-peptide monoclonal antibodies. J. Clin. Pathol. 46, 993-996 (1993).